SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-027398
Filing Date
2022-02-25
Accepted
2022-02-25 17:17:12
Documents
1
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm227764-5_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm227764-5_4aseq1.xml 4/A 7499
  Complete submission text file 0001104659-22-027398.txt   8991
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Martin Tami Tillotson (Reporting) CIK: 0001539494 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35518 | Film No.: 22681935